메뉴 건너뛰기




Volumn 14, Issue 5, 2002, Pages 247-250

Use of clopidogrel loading, enoxaparin, and double-bolus eptifibatide in the setting of early percutaneous coronary intervention for acute coronary syndromes

Author keywords

Angina; Angioplasty; Anticoagulation; Stent

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; HEPARIN;

EID: 0036246812     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (21)

References (13)
  • 1
    • 2242477091 scopus 로고
    • Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty: The EPIC Investigation
    • (1994) N Engl J Med , vol.330 , pp. 956-961
  • 2
    • 1842369101 scopus 로고    scopus 로고
    • Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
    • (1997) N Engl J Med , vol.336 , pp. 1689-1696
  • 3
    • 0032508297 scopus 로고    scopus 로고
    • Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
    • (1998) Lancet , vol.352 , pp. 87-92
  • 4
    • 0035897706 scopus 로고    scopus 로고
    • The ESPRIT (Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy) trial. Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention. The ESPRIT trial: A randomized controlled trial
    • (2001) JAMA , vol.285 , pp. 2468-2473
    • O'Shea, J.C.1    Hafley, G.E.2    Greenberg, S.3
  • 5
    • 0008926519 scopus 로고    scopus 로고
    • Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
    • (1998) N Engl J Med , vol.339 , pp. 436-443
  • 6
    • 0034622539 scopus 로고    scopus 로고
    • Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)
    • (2000) Circulation , vol.102 , pp. 624-629
    • Bertrand, M.E.1    Rupprecht, H.J.2    Urban, P.3    Gershlick, A.H.4
  • 7
    • 0034762075 scopus 로고    scopus 로고
    • Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement
    • (2001) Heart , vol.85 , pp. 92-93
    • Muller, I.1    Seyfarth, M.2    Rudiger, S.3
  • 8
    • 8544279582 scopus 로고    scopus 로고
    • A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group
    • (1997) N Engl J Med , vol.337 , pp. 447-452
    • Cohen, M.1    Demers, C.2    Gurfinkel, E.P.3
  • 9
    • 0032870952 scopus 로고    scopus 로고
    • Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q wave myocardial infarction. Results of the TIMI B Trial
    • (1999) Circulation , vol.100 , pp. 1593-1601
    • Antman, E.1    McCabe, C.2    Gurfinkel, E.3
  • 10
    • 0035949117 scopus 로고    scopus 로고
    • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT 3 randomised trial in acute myocardial infarction
    • (2001) Lancet , vol.358 , pp. 605-613
  • 11
    • 0035318112 scopus 로고    scopus 로고
    • Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention
    • The NICE 1 and NICE 4 (National Investigators Collaborating on Enoxaparin) Investigators
    • (2001) J Invas Cardiol , vol.13 , pp. 272-278
    • Kereiakes, D.J.1    Grines, C.2    Fry, E.3
  • 13
    • 0009078325 scopus 로고    scopus 로고
    • Data on file with AVENTIS


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.